XML 28 R14.htm IDEA: XBRL DOCUMENT v3.24.1
FAIR VALUES OF FINANCIAL INSTRUMENTS
12 Months Ended
Dec. 31, 2023
Fair Values Of Financial Instruments  
FAIR VALUES OF FINANCIAL INSTRUMENTS

5. FAIR VALUES OF FINANCIAL INSTRUMENTS

 

FASB ASC Section 820, Fair Value Measurements and Disclosures, establishes a three-level hierarchy for fair value measurements which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of inputs that may be used to measure fair value are as follows:

 

Level 1: Quoted prices (unadjusted) or identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date;

 

Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data; and

 

Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions that market participants would use in pricing an asset or liability.

 

 

Cash and cash equivalents and accounts payable are reflected in the consolidated balance sheets at their approximate estimated fair values primarily due to their short-term nature. The fair values of securities available for sale are determined by relying on the securities’ relationship to other benchmark quoted securities and classified its investments as Level 2 items in both 2023 and 2022. There were no transfers of assets or liabilities between Level 1 and Level 2 and no transfers in or out of Level 3 during the years ended December 31, 2023 and 2022. The changes in Level 3 liabilities were the result of changes in the fair value of the earn-out milestone liability included in earnings and in-process R&D. The earnout milestone liability is valued using a risk-adjusted assessment of the probability of payment of each milestone, discounted to present value using an estimated time to achieve the milestone (see Note 13).

 

Assets and liabilities measured at fair value are summarized below:

 

   Total Fair Value  

Quoted Prices

in Active Markets

for Identical

Assets/Liabilities (Level 1)

  

Significant Other

Observable Inputs

(Level 2)

  

Significant

Unobservable

Inputs
(Level 3)

 
Assets:                    
                     
Recurring items as of December 31, 2023                    
Corporate debt securities, available for sale  $9,857,087   $9,857,087   $   $ 
                     
Recurring items as of December 31, 2022                    
Corporate debt securities and U.S. treasury obligations, available for sale  $21,254,485   $21,254,485   $   $ 
                     
Non-recurring items as of December 31, 2022                    
In-process R&D  $   $   $   $ 
                     
Liabilities:                    
                     
Recurring items as of December 31, 2022                    
Earn-out milestone liability  $-   $-   $-   $-